CT-388

· Carmot Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT-388, covering 2025-10-20 to 2025-10-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus [Phase 1]

See pricing